Financhill
Buy
63

JNJ Quote, Financials, Valuation and Earnings

Last price:
$155.25
Seasonality move :
3.97%
Day range:
$153.94 - $156.39
52-week range:
$140.68 - $168.85
Dividend yield:
3.15%
P/E ratio:
26.97x
P/S ratio:
4.27x
P/B ratio:
5.36x
Volume:
7.2M
Avg. volume:
8.8M
1-year change:
-0.4%
Market cap:
$375.9B
Revenue:
$88.8B
EPS (TTM):
$5.79

Analysts' Opinion

  • Consensus Rating
    Johnson & Johnson has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $168.64, Johnson & Johnson has an estimated upside of 8.01% from its current price of $156.13.
  • Price Target Downside
    According to analysts, the lowest downside price target is $150.00 representing 3.93% downside risk from its current price of $156.13.

Fair Value

  • According to the consensus of 18 analysts, Johnson & Johnson has 8.01% upside to fair value with a price target of $168.64 per share.

JNJ vs. S&P 500

  • Over the past 5 trading days, Johnson & Johnson has overperformed the S&P 500 by 1.97% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Johnson & Johnson does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Johnson & Johnson has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Johnson & Johnson reported revenues of $22.5B.

Earnings Growth

  • Johnson & Johnson earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Johnson & Johnson reported earnings per share of $1.41.
Enterprise value:
391.4B
EV / Invested capital:
--
Price / LTM sales:
4.27x
EV / EBIT:
22.94x
EV / Revenue:
4.41x
PEG ratio (5yr expected):
0.05x
EV / Free cash flow:
20.57x
Price / Operating cash flow:
18.54x
Enterprise value / EBITDA:
17.39x
Gross Profit (TTM):
$61.4B
Return On Assets:
8.05%
Net Income Margin (TTM):
15.84%
Return On Equity:
20.88%
Return On Invested Capital:
13.37%
Operating Margin:
16.17%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $87.4B $85.2B $88.8B $21.4B $22.5B
Gross Profit $59.6B $58.6B $61.4B $14.6B $15.4B
Operating Income $23.4B $23.4B $21.8B $4.6B $3.6B
EBITDA $28B $23.3B $22.5B $6.8B $3.6B
Diluted EPS $6.74 $13.81 $5.79 $1.67 $1.41
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $51.2B $61B $55.3B $53.5B --
Total Assets $174.9B $182B $187.4B $167.6B --
Current Liabilities $42.5B $45.2B $55.8B $46.3B --
Total Liabilities $111.6B $108B $110.6B $98.8B --
Total Equity $63.3B $74B $76.8B $68.8B --
Total Debt $35.3B $33.8B $39.6B $29.3B --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $21.6B $20.3B $25.1B $7.5B $8B
Cash From Investing -$13.3B -$2.3B -$18.5B $2.5B -$3.1B
Cash From Financing -$14B -$9.5B -$6.4B -$11.3B -$9.9B
Free Cash Flow $17.7B $15.7B $19B $6.5B $5.7B
JNJ
Sector
Market Cap
$375.9B
$43.5M
Price % of 52-Week High
92.47%
47.5%
Dividend Yield
3.15%
0%
Shareholder Yield
5.79%
-0.74%
1-Year Price Total Return
-0.4%
-35.82%
Beta (5-Year)
0.520
0.753
Dividend yield:
3.15%
Annualized payout:
$4.91
Payout ratio:
62.84%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $153.65
200-day SMA
Buy
Level $153.90
Bollinger Bands (100)
Buy
Level 147.02 - 161.02
Chaikin Money Flow
Buy
Level 1B
20-day SMA
Buy
Level $150.39
Relative Strength Index (RSI14)
Buy
Level 65.65
ADX Line
Buy
Level 26.83
Williams %R
Sell
Level -2.2461
50-day SMA
Buy
Level $148.26
MACD (12, 26)
Buy
Level 2.08
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Neutral
Level 165.4M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
Buy
CA Score (Annual)
Level (-0.2874)
Buy
Beneish M-Score (Annual)
Level (-2.7072)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-2.0096)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Stock Forecast FAQ

In the current month, JNJ has received 7 Buy ratings 11 Hold ratings, and 0 Sell ratings. The JNJ average analyst price target in the past 3 months is $168.64.

  • Where Will Johnson & Johnson Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Johnson & Johnson share price will rise to $168.64 per share over the next 12 months.

  • What Do Analysts Say About Johnson & Johnson?

    Analysts are divided on their view about Johnson & Johnson share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Johnson & Johnson is a Sell and believe this share price will drop from its current level to $150.00.

  • What Is Johnson & Johnson's Price Target?

    The price target for Johnson & Johnson over the next 1-year time period is forecast to be $168.64 according to 18 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.

  • Is JNJ A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Johnson & Johnson is a Hold. 11 of 18 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of JNJ?

    You can purchase shares of Johnson & Johnson via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Johnson & Johnson shares.

  • What Is The Johnson & Johnson Share Price Today?

    Johnson & Johnson was last trading at $155.25 per share. This represents the most recent stock quote for Johnson & Johnson. Yesterday, Johnson & Johnson closed at $156.13 per share.

  • How To Buy Johnson & Johnson Stock Online?

    In order to purchase Johnson & Johnson stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Will Palantir Stock Be Worth in 2030?
What Will Palantir Stock Be Worth in 2030?

Palantir Technologies (NYSE: PLTR) has emerged from a growth slowdown…

Is Rollins Stock a Buy, Sell or Hold?
Is Rollins Stock a Buy, Sell or Hold?

Pest control giant Rollins (NYSE:ROL) is the parent company of…

Why Did Bill Ackman Buy Uber?
Why Did Bill Ackman Buy Uber?

In early 2025, billionaire investor Bill Ackman, CEO of Pershing…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 111x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
65
ATEX alert for Feb 12

Anterix [ATEX] is down 0.72% over the past day.

Buy
87
GDS alert for Feb 12

GDS Holdings [GDS] is up 0.32% over the past day.

Sell
30
SPSC alert for Feb 12

SPS Commerce [SPSC] is up 0.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock